← All medicines

Cancer medicines

Glofitamab-gxbm injection

Independent educational summary · Sources checked November 20, 2026

A bispecific antibody for specified previously treated large B-cell lymphomas.

Profile scope: Glofitamab-gxbm injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Muscle or joint discomfort, fatigue, swelling, rash, or bowel changes may occur.

Serious risks and warning signs

Cytokine-release syndrome can be life-threatening, and serious neurological reactions or infection require assessment. Fever, confusion, breathing difficulty, severe weakness, or other acute changes needs immediate contact. Premedication and monitored step-up dosing are essential.

A question for your healthcare team

What current observation schedule and emergency plan apply during early doses and after I leave?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.